New York State Common Retirement Fund Celldex Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 22,237 shares of CLDX stock, worth $435,178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,237
Previous 22,237
-0.0%
Holding current value
$435,178
Previous $756,000
25.66%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$99.1 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$91.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$76 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$73.5 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$69.6 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $915M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...